All the updated news related to eisai

All the news related to eisai updated in real time

Found 7

foreisai

Order by:

‘Major breakthrough’ as dementia drug found to ‘slow cognitive decline’

A dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug has been found to reduce memory decline among patients with early-stage disease. Lecanemab was found to slow decline in participants’ memory and thinking. ...

28 Sept 2022 at 14:45

Local News

'A historic moment' - Research finds new drug slows memory decline in dementia patients

A British dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug made in Japan has been found to reduce memory decline among patients with early-stage disease. Lecanemab was found to slow decline in ...

28 Sept 2022 at 18:33

New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment

Experts have hailed the “beginning of the end” in the search for effective Alzheimer’s treatments after a new drug reduced memory decline among patients with early stages of the disease. Lecanemab, which is designed to target ...

30 Nov 2022 at 02:38

Breakthrough Alzheimer’s drug could be in UK use in a year but only for minority

(adds detail in final three pars) Patients could be getting breakthrough Alzheimer’s drug in a year, experts have said, but only a small proportion of patients will benefit unless more is done to boost dementia services in ...

23 Nov 2022 at 18:56

Charity urges Streeting to ‘act’ in wake of Alzheimer’s drug announcements

A charity has written to Health Secretary Wes Streeting, urging him to step in after it was announced that a drug shown to slow the progression of Alzheimer’s disease may not be rolled out on the NHS in England. The ...

22 Aug 2024 at 10:13

Medicines regulator set to give Alzheimer’s drug green light

The UK’s medicines regulator is set to approve a drug that has been shown to slow the progression of Alzheimer’s disease. Lecanemab, developed by pharmaceutical company Eisai, is a targeted antibody treatment that ...

22 Aug 2024 at 08:14

Alzheimer’s drugs rejected for NHS because benefits ‘too small’ to justify cost

Two drugs to treat Alzheimer’s disease have been rejected for use on the NHS because their benefits are “too small” to justify their cost, the health spending watchdog has said. The National Institute for Health ...

19 Jun 2025 at 00:01

Years
2025

Iconic Media is Ireland's largest independently owned regional newspaper and media group, with an unrivalled audience in print, online and mobile. We have 19 regional newspapers and 21 digital sites.

Iconic Digital Titles

Iconic Print Titles

Letterkenny Live

This publication supports the work of the Press Council of Ireland and Office of the Press Ombudsman, and our staff operate within the Code of Practice of the Press Council. You can obtain a copy of the Code, or contact the Council, at www.presscouncil.ie, Lo-call 1800 208 080 or email: info@presscouncil.ie.